- Patent Title: Specific bacteria for their use as a medicament, in particular for controlling excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases
-
Application No.: US15591389Application Date: 2017-05-10
-
Publication No.: US10681932B2Publication Date: 2020-06-16
- Inventor: Claude Vincent
- Applicant: INTERNATIONAL NUTRITION RESEARCH COMPANY
- Applicant Address: LU Luxembourg
- Assignee: INTERNATIONAL NUTRITION RESEARCH COMPANY
- Current Assignee: INTERNATIONAL NUTRITION RESEARCH COMPANY
- Current Assignee Address: LU Luxembourg
- Agency: Baker, Donelson, Bearman, Caldwell & Berkowitz PC
- Agent Robin L. Teskin
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4ea32b5b
- Main IPC: A23L33/135
- IPC: A23L33/135 ; A61K9/00 ; A61P3/00 ; C12N1/20 ; A61P3/04 ; A61K35/74 ; A61K35/00 ; C12R1/145 ; C12R1/01 ; A23P10/30 ; A61K45/06
Abstract:
The object of the invention are compositions and medical treatment methods with an inheritable, Gram-negative, strictly anaerobic and commensal bacterium of the family Christensenellaceae belonging to an OTU (Operational Taxonomic Unit) characterized by a 16S rRNA sequence SEQ ID NO: 1 or to an OTU characterized by a 16S rRNA sequence SEQ ID NO: 2.
Public/Granted literature
Information query
